Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;402(4):1611-23.
doi: 10.1007/s00216-011-5581-3. Epub 2011 Dec 16.

Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry

Affiliations

Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry

Bjorn J A Berendsen et al. Anal Bioanal Chem. 2012 Feb.

Abstract

A liquid chromatography-tandem mass spectrometry method for the analysis of seven antiviral drugs, zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine, rimantadine and arbidol, in poultry muscle is reported. The antiviral drugs were extracted from the homogenized poultry muscle sample using methanol. The extract was purified using tandem solid-phase extraction combining a cation exchange cartridge and a phenylboronic acid cartridge. To prevent excessive matrix effects, the analytes were separated from the matrix constituents using a column-switch liquid chromatography system combining a reversed-phase and a Hypercarb analytical column. Detection was carried out using tandem mass spectrometry. The method was fully validated according to 2002/657/EC [1] and proved to be adequate for quantification and confirmation of zanamivir and ribavirin at 10 μg kg(-1), oseltamivir, oseltamivir carboxylate, amantadine and rimantadine at levels below 1.0 μg kg(-1) and for qualitative confirmatory analysis of arbidol at levels below 1 μg kg(-1).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structures of a zanamivir, b ribavirin, c oseltamivir, d oseltamivir carboxylate, e rimantadine, f amantadine and g arbidol
Fig. 2
Fig. 2
Schematic representation of (a) the dual SPE procedure and (b) the LC procedure. Z zanamivir, RB ribavirin, O oseltamivir, OC oseltamivir carboxylate, AM amantadine, RM rimantadine, AB arbidol
Fig. 3
Fig. 3
Matrix effects (signal MMRS/signal standard) of the antiviral drugs when using zic-HILIC (light grey), C18 (medium grey), Hypercarb (dark grey) and the column-switch set-up (black). 100% corresponds to no matrix effects
Fig. 4
Fig. 4
Relative amount of antiviral drugs in the breakthrough during application of a 50 μg kg−1 spiked poultry muscle sample (light grey), the breakthrough during washing (dark grey) and the elution (black) of (a) the Strata-X C and (b) the PBA SPE cartridge
Fig. 5
Fig. 5
(a) Matrix effect (signal MMRS/signal standard) obtained for the antiviral drugs after the clean-up procedure when using RP C18 (light grey) and the column-switch set-up (dark grey) as the chromatographic system (n = 5) and (b) the recovery of the sample clean-up procedure (n = 5)
Fig. 6
Fig. 6
SRM chromatograms of (a) blank poultry muscle sample spiked with zanamivir and ribavirin at 10 μg kg−1 including the internal standards and (b) blank poultry muscle sample spiked with the internal standards only
Fig. 7
Fig. 7
SRM chromatograms of (a) blank poultry muscle sample spiked with oseltamivir, oseltamivir carboxylate, rimantadine, amantadine and arbidol at 2.5 μg kg−1 including the internal standards and (b) blank poultry muscle sample spiked with the internal standards only

References

    1. EC (2002) Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Europ Commun L221:8–36
    1. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5 Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374–1385. - PubMed
    1. WHO (2011) Avian influenza, fact sheet. WHO, Geneva
    1. Malik Peiris JS, De Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev. 2007;20:243–267. - PMC - PubMed
    1. Mumford E, Bishop J, Hendrickx S, Embarek P, Perdue M. Avian influenza H5N1: risks at the human-animal interface. Food Nutr Bull. 2007;28:S357–S363. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources